Lyon

With more than 1,500 employees, the Lyon area is now Boehringer Ingelheim's center of activity in France and home to six of the company’s ten French sites. The French headquarters and the Animal Health headquarters are situated in the life sciences district of Lyon. In this region, Boehringer Ingelheim is present across the entire animal health value chain: research and development, production, and supply of veterinary products. Since 2015, almost EUR 500 million have been invested into the R&D and production sites in Lyon.

Veterinary vaccine production sites, Lyon Porte-des-Alpes

The Grand Lyon Industrial Biologic Center is one of the largest supply centers in Boehringer Ingelheim’s global network and gathers three core facilities:

Lyon-Porte-des-Alpes, a Research & Development and Production center for veterinary vaccines, particularly expert in infectious diseases.
Lentilly, a distribution center, responsible for packaging and storage of veterinary vaccines.
Lyon-Jonage, a strategic vaccine production center for veterinary public health, which represents a major investment of EUR 300 million and will be operational in 2023.

On top of that, Lyon has two other major sites: While Saint-Vulbas is a global clinical research center for veterinary vaccines and pharmaceutical products, Lyon-Gerland is currently in the process of being reconverted.

Sites Around the World

Ingelheim

The company headquarters of Boehringer Ingelheim are located in Ingelheim, Germany. It is the largest site, producing all new active ingredients and medications during the market launch.

Shanghai

Shanghai, China, serves as an important hub within the global network of all three business areas – Human Pharma, Animal Health and Biopharmaceutical Contract Manufacturing.